These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8109910)

  • 21. [Anti-retroviral treatment. Treatment modification: toxicity management].
    Ocaña I; Laguna F; Pulido F; Bascuñana A
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():31-5. PubMed ID: 9053025
    [No Abstract]   [Full Text] [Related]  

  • 22. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
    Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
    Pezeshkpour G; Illa I; Dalakas MC
    Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV or zidovudine myopathy?
    Dalakas M
    Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
    [No Abstract]   [Full Text] [Related]  

  • 25. [Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
    Moreno García M
    Med Clin (Barc); 1997 Feb; 108(7):266-71. PubMed ID: 9121196
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 27. Zidovudine and human immunodeficiency virus-associated peripheral neuropathies: low intake in patients with mononeuropathy multiplex and no evidence for neurotoxicity.
    Lefaucheur JP; Authier FJ; Verroust J; Gherardi RK
    Muscle Nerve; 1997 Jan; 20(1):106-9. PubMed ID: 8995592
    [No Abstract]   [Full Text] [Related]  

  • 28. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
    Hester EK; Peacock JE
    AIDS; 1998 Mar; 12(4):439-40. PubMed ID: 9520175
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
    Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
    Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroviruses and inflammatory myopathies in humans and primates.
    Dalakas MC
    Baillieres Clin Neurol; 1993 Nov; 2(3):659-91. PubMed ID: 8156147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV disease: a review for the family physician. Part I. Evaluation and conventional therapy.
    Brooke GL; Safran GF; Perlmutter BL; Perez JA; Zatlin GS
    Am Fam Physician; 1990 Oct; 42(4):971-80. PubMed ID: 2220524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
    Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
    J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zidovudine in HIV infection.
    Drug Ther Bull; 1991 Oct; 29(21):81-2. PubMed ID: 1935595
    [No Abstract]   [Full Text] [Related]  

  • 36. [Zidovudine in asymptomatic HIV infection].
    Bornkessel B
    Med Monatsschr Pharm; 1991 Aug; 14(8):250. PubMed ID: 1921844
    [No Abstract]   [Full Text] [Related]  

  • 37. Painless periungual pyogenic granulomata associated with reverse transcriptase inhibitor therapy in a patient with human immunodeficiency virus infection.
    Williams LH; Fleckman P
    Br J Dermatol; 2007 Jan; 156(1):163-4. PubMed ID: 17199585
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV or zidovudine myopathy?
    Kieburtz K
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596
    [No Abstract]   [Full Text] [Related]  

  • 39. [Utilization of zidovudine in the early stage of HIV infection. Lower dosages lessen toxicity].
    Mahler W
    Fortschr Med; 1990 Oct; 108(31):87-8. PubMed ID: 2258132
    [No Abstract]   [Full Text] [Related]  

  • 40. Human immunodeficiency virus-associated autonomic neuropathy, drug addiction, and zidovudine treatment.
    Confalonieri F; Villa A
    Arch Intern Med; 1993 Feb; 153(3):400-1. PubMed ID: 8427545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.